statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., July 5, 2024 BRIDGEWATER...

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference Additional Positive Data from Pivotal ASPEN...

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., June 7, 2024 BRIDGEWATER...

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire BRIDGEWATER, N.J., June 5...

Unpacking the Latest Options Trading Trends in Insmed

Insmed to Host Commercial Webinar on June 4, 2024

Insmed to Host Commercial Webinar on June 4, 2024 Insmed to Host Commercial Webinar on June 4, 2024 PR Newswire BRIDGEWATER, N.J., May 30, 2024 BRIDGEWATER, N.J., May 30, 2024 /PRNewswire/ --Insmed...

Insmed Announces Pricing of $650 Million Public Offering of Common Stock

Insmed Announces Pricing of $650 Million Public Offering of Common Stock Insmed Announces Pricing of $650 Million Public Offering of Common Stock PR Newswire BRIDGEWATER, N.J., May 30, 2024...

Insmed CEO on lung disease treatment and path forward

Insmed CEO on lung disease treatment and path forward...

Insmed Announces Proposed $500 Million Public Offering of Common Stock

Insmed Announces Proposed $500 Million Public Offering of Common Stock Insmed Announces Proposed $500 Million Public Offering of Common Stock PR Newswire BRIDGEWATER, N.J., May 28, 2024 BRIDGEWATER...

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Volume	1.42M
52-Wk High	$78.87
52-Wk Low	$20.94

INSM Insmed Inc

About

Feed

News

Sentiment

Earnings

Fundamentals